SCHEMBL4487313

SCHEMBL4487313

CN(C)Cc1ccc(N/C(=C2\C(=O)Nc3cc(F)ccc32)c2cc(F)c(F)c(F)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.38
BRD4 O60885 1/20 0.37
DYRK1A Q13627 1/20 0.36
TGM2 P21980 1/20 0.35
CASP3 P42574 2/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
PDGFRB P09619 2/20 0.35
LSS P48449 1/20 0.34
AURKB Q96GD4 2/20 0.34
MCHR1 Q99705 2/20 0.34
FLT3 P36888 4/20 0.33
AURKA O14965 1/20 0.33
PDGFRA P16234 1/20 0.33
KDR P35968 1/20 0.33
AURKC Q9UQB9 1/20 0.33
MET P08581 1/20 0.33
MERTK Q12866 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
CTNNB1 P35222 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4487317 1.00 BACE1 (0.38) BACE1BRD4DYRK1ATGM2CASP3
SCHEMBL4504089 0.89 BACE1 (0.43) BACE1BRD4DYRK1ATGM2CASP3
SCHEMBL4504092 0.89 BACE1 (0.43) BACE1BRD4DYRK1ATGM2CASP3
SCHEMBL228331 0.88 BACE1 (0.40) BACE1BRD4DYRK1ATGM2CASP3
SCHEMBL228332 0.88 BACE1 (0.40) BACE1BRD4DYRK1ATGM2CASP3
SCHEMBL227760 0.87 BACE1 (0.39) BACE1BRD4TGM2CASP3MAOA
SCHEMBL223438 0.87 BACE1 (0.39) BACE1BRD4DYRK1ATGM2CASP3
SCHEMBL227759 0.87 BACE1 (0.39) BACE1BRD4TGM2CASP3MAOA
SCHEMBL223439 0.87 BACE1 (0.39) BACE1BRD4DYRK1ATGM2CASP3
SCHEMBL4497100 0.86 BACE1 (0.40) BACE1TGM2LSSMCHR1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR BACE1 1615/4885BRD4 2704/4885DYRK1A 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.